Jose Luis Magana, File, Associated Press
WASHINGTON — Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.
The health insurance program for seniors long ago flagged compounded drugs manufactured without Food and Drug Administration oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.
In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.
But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.
Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.
- Creeping landslide devouring part of Jackson,...
- Film about man's crusade against child sex...
- Photo gallery: Celebrating Easter across the...
- Jelly beans, chocolate and plastic eggs:...
- See which books were most frequently...
- 13th body pulled from snow in Everest avalanche
- Costa Rican a celebrity after certified miracle
- Public smoke-out marks pot holiday in Colorado
- Utah, Oklahoma same-sex marriage cases... 47
- Obama: 8 million signed up for health care 29
- Appeals judges question right to sue in... 28
- Texas seizes FLDS Church's secluded ranch 24
- Police: Student ate more pot than... 19
- Sentenced but never jailed, robber who... 17
- Supreme Court weighs ban on false... 15
- Get married, stay married? No fault... 14